Ingredient
Teprenone
Teprenone is flagged for pregnancy and trying to conceive. The concern behind the strongest flag is absorbed into the body.
- Geranylgeranylacetone
- GGA
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 2 of 6
- Counting avoid, high risk and medium risk
- Last checked
- 15 September 2026
- The day this assessment was read from the catalogue
Teprenone and pregnancy
Caution Advised
- Absorbed into the body
Teprenone is a cell-communicating ingredient that works by inducing heat shock proteins and providing antioxidant benefits to protect skin cells from environmental stress. While used in some cosmetic formulations for its protective properties, it has limited safety data specific to pregnancy. The primary concern is the lack of specific reproductive toxicity studies for topical cosmetic use during pregnancy. While teprenone has been used as an oral medication in Japan for decades with a generally favorable safety profile, the systemic absorption and effects of topical application during pregnancy have not been well-characterized. The ingredient's ability to influence cellular signaling pathways raises theoretical concerns about potential effects on fetal development. Due to insufficient pregnancy-specific safety data and the ingredient's bioactive nature as a cell-communicating compound, many healthcare providers recommend a precautionary approach. While no specific warnings exist from ACOG or other major bodies, the absence of comprehensive safety data supports avoiding unnecessary exposure during pregnancy when safer, well-studied alternatives are available.
Teprenone and breastfeeding
Safe to Use
Teprenone is a cell-communicating ingredient with antioxidant properties used in skincare. When applied topically, it is expected to have minimal systemic absorption, which reduces the likelihood of significant transfer into breast milk. While specific studies on teprenone transfer to breast milk are not available, the topical route of administration and the molecular characteristics of this ingredient suggest limited systemic bioavailability. The compound's use in cosmetic formulations typically involves low concentrations applied to intact skin, further minimizing potential exposure to breastfed infants. Given the limited systemic absorption expected from topical use and the absence of reported concerns in available literature, teprenone is considered low-risk for breastfeeding mothers. However, as with any ingredient lacking extensive lactation-specific data, applying products away from the breast area and ensuring adequate time between application and breastfeeding can further minimize any theoretical exposure.
Teprenone and postpartum
Safe to Use
Teprenone functions as a cell-communicating ingredient with antioxidant properties that may support skin recovery after pregnancy. Its ability to induce heat shock proteins can help protect stressed skin cells and promote cellular resilience during the postpartum period. For postpartum women not breastfeeding, teprenone presents minimal safety concerns. The ingredient may offer benefits for skin that has undergone the physiological changes of pregnancy, including supporting barrier function and providing antioxidant protection. No specific contraindications exist for postpartum use when not breastfeeding.
Teprenone and trying to conceive
Caution Advised
Teprenone is a cell-communicating ingredient with antioxidant properties. For women trying to conceive, the lack of reproductive safety data creates uncertainty about its use during the preconception period. While no specific evidence suggests teprenone negatively affects fertility or early conception, the limited safety data for this bioactive ingredient warrants caution. Since pregnancy may occur before it is detected, and given teprenone's classification as medium-risk during pregnancy, many healthcare providers recommend discontinuing use when actively trying to conceive. This precautionary approach ensures no inadvertent exposure during the critical early weeks of pregnancy when women may not yet know they have conceived.
Teprenone and PCOS
Safe to Use
Teprenone is a cell-communicating antioxidant ingredient that supports skin health through cellular protection mechanisms. For women with PCOS, it offers potential benefits without interfering with hormonal pathways or metabolic function. Unlike hormone-active ingredients, teprenone works through cellular signaling related to stress response rather than endocrine mechanisms. This makes it suitable for PCOS management, particularly as oxidative stress is often elevated in PCOS. The ingredient's antioxidant properties may help address inflammation commonly associated with the condition. No evidence suggests teprenone affects androgen levels, insulin sensitivity, or other PCOS-related hormonal imbalances. The ingredient can be safely incorporated into skincare routines for women managing PCOS, potentially offering anti-inflammatory benefits without hormonal disruption.
Teprenone and general use
Safe to Use
Teprenone (geranylgeranylacetone) is a cell-communicating ingredient that functions as an antioxidant and cellular protector in cosmetic formulations. It works by inducing heat shock proteins, which help cells defend against environmental stressors and maintain healthy function. For the general population, teprenone has a favorable safety profile based on its long history of use in pharmaceutical contexts and emerging cosmetic applications. No significant adverse effects have been reported with topical use. The ingredient is well-tolerated and provides antioxidant benefits that support overall skin health. While not as extensively studied in cosmetics as some other antioxidants, teprenone's established safety record in other applications and its mechanism of action support its use in skincare products for the general public. It offers a unique approach to cellular protection that complements other antioxidant strategies.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Teprenone, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store